AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MeVis Medical Solutions AG

Declaration of Voting Results & Voting Rights Announcements Oct 13, 2017

287_dva_2017-10-13_355fae64-eaf8-4b06-852b-2776037918d1.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

Voting Rights Announcements | 13 October 2017 16:06

MeVis Medical Solutions AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

MeVis Medical Solutions AG

13.10.2017 / 16:06

Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuerMeVis Medical Solutions AG

Caroline-Herschel-Str. 1

28359 Bremen

Germany

2. Reason for notification

X Acquisition/disposal of shares with voting rights
Acquisition/disposal of instruments
Change of breakdown of voting rights
Other reason:

3. Details of person subject to the notification obligation

Name: City and country of registered office:
Varian Medical Systems, Inc. Wilmington, Delaware

United States of America (USA)

4. Names of shareholder(s)

holding directly 3% or more voting rights, if different from 3.

5. Date on which threshold was crossed or reached:12 Oct 2017

6. Total positions

% of voting rights attached to shares

(total of 7.a.)
% of voting rights through instruments

(total of 7.b.1 + 7.b.2)
total of both in %

(7.a. + 7.b.)
total number of voting rights of issuer
Resulting situation 0 % 0 % 0 % 1820000
Previous notification 73.52 % n/a % n/a % /

7. Notified details of the resulting situation

a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN absolute in %
direct

(Sec. 21 WpHG)
indirect

(Sec. 22 WpHG)
direct

(Sec. 21 WpHG)
indirect

(Sec. 22 WpHG)
DE000A9LBFE4 0 0 0 % 0 %
Total 0 0 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG

Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
%
Total %

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG

Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
%
Total %

8. Information in relation to the person subject to the notification obligation

X Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting:
Holding position after general meeting: % (equals voting rights)

10. Other explanatory remarks:

The shares of the issuer were transferred from VMS Deutschland Holdings GmbH to Varex Imaging Deutschland AG.


13.10.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Internet: http://www.mevis.de
End of News DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.